ALAUNOS THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.23 USD | -0.81% |
|
-26.35% | +15.98% |
| Apr. 01 | Alaunos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 05 | North American Morning Briefing : S&P 500 Futures -2- | DJ |
Chart calendar Alaunos Therapeutics, Inc.
c7e7237e.h_UW72W8zXjy6mYuVsxz6Oq_3BaE7jfGB_Z39W1rlGY.xpRyqiTfiAiAkiF8OJUlmLPphWzN2HacUL0CjBkA2QHAkEOZFMWvOcWACQ~26a2a3d35657ab3b6776c0d824511d69
Upcoming events on Alaunos Therapeutics, Inc.
Past events on Alaunos Therapeutics, Inc.
| 2024-01-31 | Reverse Split: 1 of 15 |
| 2023-11-14 07:30 am | Q3 2023 Earnings Release |
| 2023-08-14 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-30 04:27 pm | Hawaii Global Summit - Dr. Collinson-Pautz |
| 2023-06-06 09:00 am | Annual General Meeting |
| 2023-06-03 09:00 am | American Society of Clinical Oncology Conference - Abstract No:2547 |
| 2023-05-10 09:00 am | Q1 2023 Earnings Call |
| 2023-05-10 07:00 am | Q1 2023 Earnings Release |
| 2023-04-17 11:45 am | Needham Healthcare Conference |
| 2023-04-03 | Cantor The Future of Oncology Virtual Symposium |
| 2023-03-07 08:30 am | Q4 2022 Earnings Call |
| 2023-03-07 07:00 am | Q4 2022 Earnings Release |
| 2022-11-14 08:30 am | Q3 2022 Earnings Call |
| 2022-11-14 07:00 am | Q3 2022 Earnings Release |
| 2022-11-10 10:40 am | Society for Immunotherapy of Cancer Meeting - Abstract No: 227 |
| 2022-09-30 08:30 am | CRI-ENCI-AACR International Cancer Immunotherapy Conference - Objective Clinical Response By KRAS Mu |
| 2022-09-27 | Cantor Oncology, Hematology & HemeOnc Conference |
| 2022-09-11 | Morgan Stanley Global Healthcare Conference |
| 2022-09-07 | Wells Fargo Healthcare Conference |
| 2022-08-15 08:30 am | Interim 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,40 0,27 49.62% | 2,92 1,94 50.85% | 0,01 0,00 25% | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -57,2 -48,9 -17.03% | -79,2 -70,5 -12.39% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -57,9 -56,1 -3.07% | -80,4 -78,5 -2.39% | -73,3 -85,8 14.52% | -35,1 -42,0 16.37% | -34,3 -34,1 -0.63% | -8,31 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -118 -116 -1.13% | -80,0 -78,3 -2.18% | -78,8 -87,2 9.72% | -37,7 -40,9 7.67% | -35,1 -35,2 0.27% | -9,55 |
|
Net income Million USD | Released Forecast Spread | -118 -116 -1.13% | -80,0 -78,2 -2.31% | -78,8 -86,1 8.56% | -37,7 -43,9 14.09% | -35,1 -35,2 0.27% | -9,55 |
|
EPS USD | Released Forecast Spread | -10,5 -10,4 -0.57% | -5,70 -5,57 -2.27% | -5,55 -5,96 6.83% | -2,55 -2,65 3.77% | -2,20 -2,25 2.22% | -0,60 |
| Announcement Date | 02/03/20 | 25/02/21 | 30/03/22 | 07/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 2,91 0,00 - | 0,01 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -10,3 -19,2 46.39% | -9,09 -15,1 40.01% | -9,23 -10,9 15.15% | -8,26 -15,1 45.45% | -8,52 -14,2 40.18% | -9,67 -9,60 -0.75% | -7,98 -10,0 20.2% | -8,66 -8,76 1.07% | -7,95 -7,49 -6.16% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,8 -20,4 42.17% | -9,79 -11,0 11.28% | -9,93 -11,0 9.73% | -8,85 -10,9 18.81% | -9,16 -11,8 22.49% | -10,0 -10,1 0.91% | -8,77 -10,4 15.52% | -8,48 -9,11 6.91% | -7,84 -8,29 5.33% |
|
Net income Million USD | Released Forecast Spread | -11,8 -19,3 38.95% | -9,79 -15,3 35.92% | -9,93 -11,0 9.73% | -8,85 -15,4 42.68% | -9,16 -14,8 38.03% | -10,0 -10,2 1.61% | -8,77 -10,4 15.52% | -8,48 -9,11 6.91% | -7,84 -8,29 5.33% |
|
EPS USD | Released Forecast Spread | -0,75 -1,26 40.68% | -0,75 -0,99 24.24% | -0,75 -1,03 26.83% | -0,60 -1,10 45.45% | -0,60 -1,00 40% | -0,60 -0,63 4.76% | -0,60 -0,66 9.09% | -0,60 -0,53 -14.29% | -2,09 -0,45 -364.44% |
| Announcement Date | 30/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 07/03/23 | 10/05/23 | 14/08/23 | 14/11/23 | 01/04/24 |
More events
Past sector events for Alaunos Therapeutics, Inc.
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TCRT Stock
- Calendar Alaunos Therapeutics, Inc.
